Urokinase-Type Plasminogen Activator clinical trials
Also written Urokinase.
How each study uses Urokinase-Type Plasminogen Activator is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Urokinase-Type Plasminogen Activator studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Jan 1978 · KINLYTIC · BLA 021846 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2020 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 9
medac GmbH (2) · National Healthcare Group, Singapore (1) · The First Affiliated Hospital of Zhengzhou University (1) · Spanish Society of Pediatric Surgery (1) · Beijing Chao Yang Hospital (1) · Second Affiliated Hospital of Nanchang University (1) · GWT-TUD GmbH (1) · University of Roma La Sapienza (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Thrombolytics source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Urokinase-Type Plasminogen Activator.
- Jun 2027Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)Phase 4 · Second Affiliated Hospital of Nanchang University
Studies
Open first, then newest update. How each study uses Urokinase-Type Plasminogen Activator is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)RecruitingPhase 4Second Affiliated Hospital of Nanchang UniversityNCT06284642Written as UrokinaseHow we know
- Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: a Randomized Controlled TrialCompletedPhase 4National Healthcare Group, SingaporeNCT06802679Written as UrokinaseHow we know
- Thrombolysis of Urokinase for Minor StrokeCompletedPhase 3The First Affiliated Hospital of Zhengzhou UniversityNCT04420351Written as Urokinase thrombolysisHow we know
- Local Thrombolytics Before Thrombectomy in STEMIStatus unknownPhase 4University of Roma La SapienzaNCT01568931Written as UrokinaseHow we know
- Urokinase Therapy in Patients With Diabetic Foot SyndromeTerminatedPhase 3medac GmbHNCT00823225Written as UrokinaseHow we know
- Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb IschemiaTerminatedPhase 3GWT-TUD GmbHNCT01638585Written as urokinaseHow we know
- Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in ChildhoodCompletedPhase 3Spanish Society of Pediatric SurgeryNCT00798278Written as UrokinaseHow we know
- Intrapleural Urokinase for Retained HemothoraxStatus unknownPhase 3National Taiwan University HospitalNCT01134237Written as urokinaseHow we know
- Urokinase Therapy in Diabetic Foot SyndromeCompletedPhase 2medac GmbHNCT00537498Written as UrokinaseHow we know
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in ChinaCompletedPhase 4Beijing Chao Yang HospitalNCT00799968Written as UrokinaseHow we know
- Dornase Alfa and Urokinase for Kids With Pleural EmpyemaStatus unknownPhase 2/3Azienda Ospedaliera di PadovaNCT00502632Written as Urokinase and Dornase alfaHow we know
Given beside what is tested · 1 — Urokinase-Type Plasminogen Activator is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Urokinase-Type Plasminogen Activator
Codes
What other systems call Urokinase-Type Plasminogen Activator · ClinicalTrials.gg INT008388
- UNII (FDA) 83G67E21XIUROKINASEConfirmed FDA, Wikidata
- RxNorm 11055Confirmed FDA, Wikidata
- Wikidata Q110969665urokinaseConfirmed FDA, Wikidata
- DrugBank DB00013One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 83G67E21XI | UROKINASE | Confirmed FDA, Wikidata |
| RxNorm | 11055 | — | Confirmed FDA, Wikidata |
| Wikidata | Q110969665 | urokinase | Confirmed FDA, Wikidata |
| DrugBank | DB00013 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.